Therapeutic interventions for Burkitt lymphoma in children (Q24235495)

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

HIV infection and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Lessons from clinical trials in African Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

HIV-associated lymphoma: the evidence for treating aggressively but with caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Rituximab for HIV-associated lymphoma: weighing the benefits and risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

AIDS and associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Use of rituximab in three children with relapsed/refractory Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Adult Burkitt leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

A sarcoma involving the jaws in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Burkitt's lymphoma and the role of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Treatment advances in adult Burkitt lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Surgical Reduction of Tumour Bulk in Management of Abdominal Burkitt's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

B-cell activation and lymphoma in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Socioeconomic constraints to effective management of Burkitt's lymphoma in south-eastern Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Epidemiology of Burkitt's lymphoma in Enugu, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Long‐term experience with burkitt's lymphoma in uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Chemotherapy of Burkitt's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Therapeutic interventions for Burkitt's lymphoma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005198.PUB3

Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study

21 January 2018

1 reference

12 December 2020

[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]

1 reference

12 December 2020

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

1 reference

12 December 2020

Biology and treatment of small non-cleaved cell lymphoma

1 reference

12 December 2020

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

The use of ibritumomab tiuxetan radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma

1 reference

12 December 2020

Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group

1 reference

12 December 2020

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

1 reference

12 December 2020

Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy

1 reference

12 December 2020

BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial

1 reference

12 December 2020

Intrathecal Chemotherapy in Burkitt's Lymphoma

1 reference

12 December 2020

Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network

1 reference

12 December 2020

[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]

1 reference

12 December 2020

Phase III Intergroup Study of Fludarabine Phosphate Compared With Cyclophosphamide, Vincristine, and Prednisone Chemotherapy in Newly Diagnosed Patients With Stage III and IV Low-Grade Malignant Non-Hodgkin's Lymphoma

1 reference

12 December 2020

Treatment of histiocytic lymphoma in Uganda adults

1 reference

12 December 2020

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children

1 reference

12 December 2020

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

1 reference

12 December 2020

Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

1 reference

12 December 2020

Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma

1 reference

12 December 2020

High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study

1 reference

12 December 2020

Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial

1 reference

12 December 2020

Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas

1 reference

12 December 2020

Burkitt Lymphoma in Children

1 reference

12 December 2020

Marginal zone B cell lymphoma of the parotid glands: results of a randomised trial comparing radiotherapy to combined therapy

1 reference

12 December 2020

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas

1 reference

12 December 2020

Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations

1 reference

12 December 2020

Malignant non-Hodgkin's lymphomas in children.

1 reference

12 December 2020

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

1 reference

12 December 2020

Cerebrospinal irradiation of Burkitt's lymphoma. Failure in preventing central nervous system relapse

1 reference

12 December 2020

Specific transfer factor with activity against epstein-barr virus reduces late relapse in endemic Burkitt's lymphoma

1 reference

12 December 2020

Conventional and Superfractionated Radiation Therapy in Burkitt's Lymphoma

1 reference

12 December 2020

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)

1 reference

12 December 2020